300 related articles for article (PubMed ID: 16476471)
1. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
[TBL] [Abstract][Full Text] [Related]
2. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
[TBL] [Abstract][Full Text] [Related]
3. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
[TBL] [Abstract][Full Text] [Related]
4. Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy.
Uberti EM; Fajardo Mdo C; Ferreira SV; Pereira MV; Seger RC; Moreira MA; Torres MD; de Nápoli G; Schmid H
Gynecol Oncol; 2009 Dec; 115(3):476-81. PubMed ID: 19818481
[TBL] [Abstract][Full Text] [Related]
5. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic actinomycin D for high-risk complete hydatidiform mole.
Limpongsanurak S
J Reprod Med; 2001 Feb; 46(2):110-6. PubMed ID: 11255809
[TBL] [Abstract][Full Text] [Related]
7. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease.
Kaneki E; Kobayashi H; Hirakawa T; Matsuda T; Kato H; Wake N
Cancer Sci; 2010 Jul; 101(7):1717-21. PubMed ID: 20518791
[TBL] [Abstract][Full Text] [Related]
8. Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience.
Sekharan PK; Sreedevi NS; Radhadevi VP; Beegam R; Raghavan J; Guhan B
J Reprod Med; 2006 Oct; 51(10):835-40. PubMed ID: 17086813
[TBL] [Abstract][Full Text] [Related]
9. Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China.
Zhao Y; Zhang W; Duan W
J Reprod Med; 2009 Feb; 54(2):88-94. PubMed ID: 19301571
[TBL] [Abstract][Full Text] [Related]
10. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
11. Endometrial sampling in patients with trophoblastic disease after suction curettage.
Lertkhachonsuk R; Treratanachat S
J Reprod Med; 2008 Aug; 53(8):634-8. PubMed ID: 18773630
[TBL] [Abstract][Full Text] [Related]
12. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
[TBL] [Abstract][Full Text] [Related]
13. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
[TBL] [Abstract][Full Text] [Related]
14. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
[TBL] [Abstract][Full Text] [Related]
15. Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
Kim SJ; Na YJ; Jung SG; Kim CJ; Bae SN; Lee C
J Reprod Med; 2007 Sep; 52(9):819-30. PubMed ID: 17939600
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
[TBL] [Abstract][Full Text] [Related]
17. The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia.
Liu Y; Ye Y; Cheng X; Lu W; Xie X; Wang X; Li X
BMC Womens Health; 2023 Jan; 23(1):1. PubMed ID: 36593459
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
[TBL] [Abstract][Full Text] [Related]
19. Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia.
Chen LM; Lengyel ER; Bethan Powell C
Gynecol Oncol; 2004 Jul; 94(1):204-7. PubMed ID: 15262143
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
